Skip to main content
. 2010 Apr 15;299(1):G215–G219. doi: 10.1152/ajpgi.00072.2010

Table 1.

Demographic characteristics

Parameter Placebo Tolterodine Darifenacin (7.5 mg) Darifenacin (15 mg)
Number 16 19 20 17
Age 32.8 ± 1.7 34.9 ± 2.4 35.8 ± 2.3 34.1 ± 2.7
Women 10 13 13 11
BMI, kg/m2 25.1 ± 1 26 ± 1 28.1 ± 1 26.7 ± 0.9

All values represent observed mean [95% confidence interval (CI)].